Showing results (231-240 of 355) with videos related to

Sort By:
Pageof 36
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 22, 2011
[Interdisciplinary management of a large Legionella outbreak in Germany]M Freudenmann, S Kurz, H von Baum, et al.
Circulation Research|February 7, 2001
Mechanisms underlying endothelial dysfunction in diabetes mellitusU Hink, H Li, H Mollnau, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 15, 2022
Defibrillator generator replacements in patients with left ventricular assist device support: The risks of hematoma and infectionJ J Eulert-Grehn, I Sterner, F Schoenrath, et al.
Journal of Public Health Management and Practice : JPHMP|July 4, 2001
Partnership for front-line success: a call for a national action agenda on workforce developmentM Y Lichtveld, J P Cioffi, E L Baker, et al.
Circulation Research|June 1, 1997
Vascular thrombin receptor regulation in hypertensive ratsQ Capers, J B Laursen, T Fukui, et al.
Journal of Visualized Experiments : Jove|September 29, 2025
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell LymphomaJulia Thiel, Jan A Schlegel, Sam Steinfeldt, et al.
Pathology Oncology Research : POR|September 9, 2021
GTF2I Mutation in Thymomas: Independence From Racial-Ethnic Backgrounds. An Indian/German Comparative StudyDeepali Jain, Prerna Guleria, Varsha Singh, et al.
International Journal of Molecular Sciences|December 11, 2025
Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse ModelsDina Mönch, Julia Thiel, Meng Dong, et al.
Genome Research|November 18, 2025
Integration of high-throughput proteomic data and complementary omics layers with PriOmicsRobin Kosch, Katharina Limm, Annette M Staiger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2014
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)M G Fury, E J Sherman, S S Rao, et al.
Pageof 36